Literature DB >> 22293860

Chagas heart disease: report on recent developments.

Fabiana S Machado1, Linda A Jelicks, Louis V Kirchhoff, Jamshid Shirani, Fnu Nagajyothi, Shankar Mukherjee, Randin Nelson, Christina M Coyle, David C Spray, Antonio C Campos de Carvalho, Fangxia Guan, Cibele M Prado, Michael P Lisanti, Louis M Weiss, Susan P Montgomery, Herbert B Tanowitz.   

Abstract

Chagas disease, caused by the parasite Trypanosoma cruzi, is an important cause of cardiac disease in endemic areas of Latin America. It is now being diagnosed in nonendemic areas because of immigration. Typical cardiac manifestations of Chagas disease include dilated cardiomyopathy, congestive heart failure, arrhythmias, cardioembolism, and stroke. Clinical and laboratory-based research to define the pathology resulting from T. cruzi infection has shed light on many of the cellular and molecular mechanisms leading to these manifestations. Antiparasitic treatment may not be appropriate for patients with advanced cardiac disease. Clinical management of Chagas heart disease is similar to that used for cardiomyopathies caused by other processes. Cardiac transplantation has been successfully performed in a small number of patients with Chagas heart disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293860      PMCID: PMC3275684          DOI: 10.1097/CRD.0b013e31823efde2

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  147 in total

Review 1.  Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.

Authors:  Francisco Javier Carod-Artal
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-05

Review 2.  The innate immune response to Trypanosoma cruzi infection.

Authors:  Hisako Kayama; Kiyoshi Takeda
Journal:  Microbes Infect       Date:  2010-03-27       Impact factor: 2.700

Review 3.  Chagas disease: 100 years after its discovery. A systemic review.

Authors:  José Rodrigues Coura; José Borges-Pereira
Journal:  Acta Trop       Date:  2010-04-09       Impact factor: 3.112

4.  The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection.

Authors:  Andréa Pereira de Souza; Ryan Sieberg; Hua Li; Hannah R Cahill; Dazhi Zhao; Tania C Araújo-Jorge; Herbert B Tanowitz; Linda A Jelicks
Journal:  Parasitol Res       Date:  2010-02-27       Impact factor: 2.289

Review 5.  Advances in eicosanoid research, novel therapeutic implications.

Authors:  Jesper Z Haeggström; Agnes Rinaldo-Matthis; Craig E Wheelock; Anders Wetterholm
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

6.  Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.

Authors:  Jian-Jun Wen; Shivali Gupta; Zhangjun Guan; Monisha Dhiman; David Condon; Charles Lui; Nisha Jain Garg
Journal:  J Am Coll Cardiol       Date:  2010-06-01       Impact factor: 24.094

Review 7.  Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

Authors:  Julio A Urbina
Journal:  Acta Trop       Date:  2009-11-10       Impact factor: 3.112

8.  Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil.

Authors:  Claudilson J C Bastos; Roque Aras; Gildo Mota; Francisco Reis; Juarez Pereira Dias; Robson Silva de Jesus; Miralba Silva Freire; Eline G de Araújo; Juliana Prazeres; Maria Fernanda Rios Grassi
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

9.  Physician awareness of Chagas disease, USA.

Authors:  Kelly K Stimpert; Susan P Montgomery
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

Review 10.  Chagas disease in Spain, the United States and other non-endemic countries.

Authors:  Joaquim Gascon; Caryn Bern; María-Jesús Pinazo
Journal:  Acta Trop       Date:  2009-07-29       Impact factor: 3.112

View more
  38 in total

1.  Characterization of Trypanosoma cruzi infectivity, proliferation, and cytokine patterns in gut and pancreatic epithelial cells maintained in vitro.

Authors:  Laura A Martello; Raj Wadgaonkar; Raavi Gupta; Fabiana S Machado; Michael G Walsh; Eduardo Mascareno; Herbert B Tanowitz; M A Haseeb
Journal:  Parasitol Res       Date:  2013-09-10       Impact factor: 2.289

2.  Monocyte glycolysis determines CD8+ T cell functionality in human Chagas disease.

Authors:  Liliana María Sanmarco; Natalia Eberhardt; Gastón Bergero; Luz Piedad Quebrada Palacio; Pamela Martino Adami; Laura Marina Visconti; Ángel Ramón Minguez; Yolanda Hernández-Vasquez; Eugenio Antonio Carrera Silva; Laura Morelli; Miriam Postan; Maria Pilar Aoki
Journal:  JCI Insight       Date:  2019-09-19

3.  Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection.

Authors:  Thabata L A Duque; Cynthia M Cascabulho; Gabriel M Oliveira; Andrea Henriques-Pons; Rubem F S Menna-Barreto
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

4.  Trypanosoma cruzi infection results in an increase in intracellular cholesterol.

Authors:  Christopher Johndrow; Randin Nelson; Herbert Tanowitz; Louis M Weiss; Fnu Nagajyothi
Journal:  Microbes Infect       Date:  2014-01-28       Impact factor: 2.700

5.  Trypanosoma cruzi invasion is associated with trogocytosis.

Authors:  Shankar Mukherjee; Aparna Mukhopadhyay; Grasiella Andriani; Fabiana Simão Machado; Anthony W Ashton; Huan Huang; Louis M Weiss; Herbert B Tanowitz
Journal:  Microbes Infect       Date:  2014-11-04       Impact factor: 2.700

6.  Alterations in glucose homeostasis in a murine model of Chagas disease.

Authors:  Fnu Nagajyothi; Regina Kuliawat; Christine M Kusminski; Fabiana S Machado; Mahalia S Desruisseaux; Dazhi Zhao; Gary J Schwartz; Huan Huang; Chris Albanese; Michael P Lisanti; Rajat Singh; Feng Li; Louis M Weiss; Stephen M Factor; Jeffrey E Pessin; Philipp E Scherer; Herbert B Tanowitz
Journal:  Am J Pathol       Date:  2013-01-12       Impact factor: 4.307

7.  High fat diet aggravates cardiomyopathy in murine chronic Chagas disease.

Authors:  Kezia Lizardo; Janeesh Plakkal Ayyappan; Min-Hui Cui; Rashmi Balasubramanya; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2018-07-31       Impact factor: 2.700

Review 8.  Imaging of small-animal models of infectious diseases.

Authors:  Linda A Jelicks; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Am J Pathol       Date:  2012-11-28       Impact factor: 4.307

9.  Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.

Authors:  Shankar Mukherjee; Nikaeta Sadekar; Anthony W Ashton; Huan Huang; David C Spray; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

10.  Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease.

Authors:  Antonio C Campos de Carvalho; David C Spray; Linda A Jelicks; Herbert B Tanowitz; Vera Maria Peters; Rosalia Mendez-Otero
Journal:  Microbes Infect       Date:  2014-09-16       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.